Download Docs
Export

DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

212527 | Orange Book

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed March 30, 2022
Ingredients DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
Dosage Form / Route ORAL and TABLET, FOR SUSPENSION
Patents No unexpired patents
Last Updated: 2 years, 4 months ago
Date Patent / Filing No. Patent and Drug Application Information